1. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Issue 10084 (27th May 2017) Authors: Fellström, Bengt C; Barratt, Jonathan; Cook, Heather; Coppo, Rosanna; Feehally, John; de Fijter, Johan W; Floege, Jürgen; Hetzel, Gerd; Jardine, Alan G; Locatelli, Francesco; Maes, Bart D; Mercer, Alex; Ortiz, Fernanda; Praga, Manuel; Sørensen, Søren S; Tesar, Vladimir; Del Vecchio, Lucia Journal: Lancet Issue: Volume 389:Issue 10084(2017) Page Start: 2117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 208. GALACTOSE DEFICIENT IGA1 (GD-IGA1) IN SKIN AND SERUM FROM PATIENTS WITH SKIN-LIMITED AND SYSTEMIC IGA VASCULITIS. (29th March 2019) Authors: Neufeld, Matthias; Molyneux, Karen; Mayer-Hain, Sarah; Barratt, Jonathan; Suzuki, Yusuke; Sunderkötter, Cord Journal: Rheumatology Issue: Volume 58(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reduced proximal tubular expression of protein endocytic receptors in proteinuria is associated with urinary receptor shedding. Issue 6 (23rd November 2017) Authors: Fatah, Hiwa; Benfaed, Nura; Chana, Ravinder S; Chunara, Mohamed H; Barratt, Jonathan; Baines, Richard J; Brunskill, Nigel J Journal: Nephrology dialysis transplantation Issue: Volume 33:Issue 6(2018) Page Start: 934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Iron Biology Status of Peritoneal Dialysis Patients May be a Risk Factor for Development of Infectious Peritonitis. Issue 4 (July 2019) Authors: Aldriwesh, Marwh; Al-Dayan, Noura; Barratt, Jonathan; Freestone, Primrose Journal: Peritoneal dialysis international Issue: Volume 39:Issue 4(2019) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled Trial. Issue 5 (September 2019) Authors: Dukka, Hari; Kalra, Philip A.; Wilkie, Martin; Bhandari, Sunil; Davies, Simon J.; Barratt, Jonathan; Squire, Iain; Odudu, Aghogho; Selby, Nicholas M.; McIntyre, Christopher; Robertson, Fiona; Taal, Maarten W. Journal: Peritoneal dialysis international Issue: Volume 39:Issue 5(2019) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is immunoglobulin A nephropathy different in different ethnic populations?. Issue 9 (1st May 2019) Authors: Yeo, See Cheng; Goh, Su Mein; Barratt, Jonathan Journal: Nephrology Issue: Volume 24:Issue 9(2019) Page Start: 885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FP201INTERIM RESULTS FROM AN ONGOING PHASE 2 STUDY EVALUATING THE USE OF A MASP-2 INHIBITOR FOR THE TREATMENT OF IGA NEPHROPATHY (IGAN). (13th June 2019) Authors: Barratt, Jonathan; Leifke, Eckhard; Whitaker, Steve; DeTulleo, Louis; Lafayette, Richard Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunological drivers of IgA nephropathy: Exploring the mucosa–kidney link. (24th November 2021) Authors: Selvaskandan, Haresh; Barratt, Jonathan; Cheung, Chee Kay Journal: International journal of immunogenetics Issue: Volume 49:Number 1(2022) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES). Issue 4 (10th February 2022) Authors: Barratt, Jonathan; Andric, Branislav; Tataradze, Avtandil; Schömig, Michael; Reusch, Michael; Valluri, Udaya; Mariat, Christophe Journal: Nephrology dialysis transplantation Issue: Volume 37:Issue 4(2022) Page Start: 805 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FC049: Nefecon® (Budesonide) is an Epigenetic Modifier in IGA Nephropathy. (3rd May 2022) Authors: Bhachu, Jasraj; Molyneux, Karen; Barratt, Jonathan; Pawluczyk, Izabella Journal: Nephrology dialysis transplantation Issue: Volume 37(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗